SPDR® S&P Health Care Equipment ETF
Most Recent
Tandem Diabetes Care Stock Has Skyrocketed in 2018
On November 21, Tandem Diabetes Care stock closed at $32.63, a ~14.69% rise from its previous day’s close of $28.45.
Medical Device ETFs: Much Higher YTD Returns in 2018
The iShares U.S. Medical Devices ETF (IHI) and the SPDR S&P Health Care Equipment ETF have returned 26.8% and $37%, respectively, YTD.
Haemonetics’s Fiscal Q1 Earnings Surpass Analyst Estimates
Haemonetics reported an 8.7% YoY increase in revenues to $229.3 million during Q1 2019 as compared to revenues of $210.9 million during Q1 2018.
What Analysts Expect from Haemonetics in Q1 2019
Haemonetics is expected to report 4.3% growth in revenues to $219.9 million during Q1 2019 as compared to $210.9 million during Q1 2018.
Exploring Antares Pharma’s Current Pipeline of Products
On October 11, 2017, Antares Pharma (ATRS) was notified by the FDA that it had found deficiencies in Xyosted.
What Analysts Are Recommending for Dentsply Sirona
According to the recommendations of 15 brokerage firms, 60.0% (or nine) of them have rated Dentsply Sirona (XRAY) a “buy,” and 33.0% (or five) have rated it a “hold.”
What Do Analysts Recommend for Dentsply Sirona?
Based on the recommendations of 16 brokerage companies, around 63% (or ten) of the analysts provided a “buy” recommendation for Dentsply Sirona.
Must-know: Shanghai free trade zone deregulates medical equipment
The Shanghai zone has been touted as China’s greatest attempt at economic reform since the first special economic zone in Schenzen in 1980.
St. Jude Medical: Key strategic stock outlook
Laser focus CEO Dan Starks told an audience last week that excessive focus on emerging markets “fails to appreciate the potential of the medical device industry.” The CEO firmly believes that straying into emerging markets implies a lack of imagination and focus. This is highly controversial, as most medical technology giants have been investing significantly […]
Must-know: Current medical devices risks and opportunities
The industry looks to be weathering the Obamacare storm, yet there are still a couple key reasons to be wary of the industry over the coming months.
Are Covidien’s layoffs good for the medical device industry?
Covidien (COV) announced that it will lay off a significant amount of employees as part of global restructuring efforts. The initiative aims to save the company up to $300 million a year by fiscal 2018.
Brazil’s medical device industry: Health coverage outlook
The upward trends of the healthcare market show that Brazil is positive for the medical device industry, suggesting rapid increases in demand as more and more people can afford the devices and pay accordingly.
Brazil’s medical device industry: Market outlook
Brazil is the largest market for medical devices in South America. This year, the market is expected to reach $8 billion in revenue.
Why the medical device tax repeal bill shouldn’t pass anytime soon
The proposed Protect Medical Innovation Act of 2013 The Protect Medical Innovation Act of 2013 has gained bi-partisan support in the House of Representatives, ensuring the bill passes when it comes to vote. But the keyword is “when” it comes to vote. Witnessing large layoffs by companies like Stryker Corp. in November 2012, lawmakers began taking […]
